Clinical Trial

DINO RCT - Treating Anxiety in Children With Autism

Recruiting
View on ClinicalTrials.gov →
Summary
Anxiety is prevalent in young children, under 7 years of age, with autism. Yet, few studies have examined anxiety interventions for this age range, and only one anxiety treatment study has included young children with cognitive and language delays. Anxiety treatment models utilizing cognitive-behavioral therapy (CBT), adapted for children with autism, are empirically supported in school-age autistic children. Further, preliminary evidence suggests CBT approaches may reduce intolerance of uncertainty (IU), a mechanistic construct that may contribute to the maintenance of anxiety in autistic children. This study seeks to address the existing gap in anxiety treatment by examining the feasibility and preliminary efficacy of a novel, telehealth CBT intervention, DINO Strategies for Anxiety and intolerance of Uncertainty Reduction (DINOSAUR), which targets both anxiety and IU in young autistic children.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-09-28; most recent amendment 2026-04-22.
Status change: Not Yet Recruiting → Recruiting 2024-01-08
Trial Details
NCT Number NCT06066983
Lead Sponsor Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions Autism Spectrum Disorder, Anxiety Disorders
Enrollment 70 participants
Start Date 2024-01-02
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-23